Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 22.2% decrease from the number of companies inspected in the previous year, when nine companies were inspected through nine inspections.
Most of the companies inspected were involved in the Food/Cosmetics sector. The second most common type of company inspected in the time period worked in the Biologics sector.
There were five companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct the organization's management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Agilent Technologies, Inc. | Devices | 03/30/2023 | No Action Indicated (NAI) |
Autumn Harp | Food/Cosmetics | 10/31/2023 | No Action Indicated (NAI) |
Ebenezer International Food, LLC | Food/Cosmetics | 01/24/2023 | Voluntary Action Indicated (VAI) |
Farrell Distributing Corporation | Food/Cosmetics | 08/15/2023 | No Action Indicated (NAI) |
University of Vermont Medical Center | Biologics | 10/26/2023 | No Action Indicated (NAI) |
Vermont Center for Reproductive Medicine | Biologics | 12/14/2023 | No Action Indicated (NAI) |
Vermont Pet Food & Supply | Veterinary | 03/31/2023 | Voluntary Action Indicated (VAI) |